Skip to main content

Improving health with data in the life sciences industry

We connect clinical research to the healthcare ecosystem, catalyzing innovation and impact. 

Leveraging real-world clinical research data to drive action

Decision-makers in life sciences trust our experienced team to provide unmatched expertise in:

  • Forwarding-thinking approaches to patient care
  • Accelerated clinical trial development
  • World-class medical technology
  • Leading-edge digital health strategies 

Explore our life sciences solutions

Clinicogenomics for Greater Data Insights

Better understand diseases and drug development opportunities.

Design and Pilot Engagement Programs

Work with the Cross Optum team and take advantage of our connections to all parts of the health system.

Empower Commercial, Brand & Access Teams

CMM is a self-service, web-based reporting tool built on our proprietary data warehouse that gives a deeper understanding of product performance.

Engage Payers with Value-Based Contracts

Generate valuable evidence, leverage real-world data and analytics and track clinical outcomes over time.

Enhance Clinical Trial Design and Performance

Modernize your approach to protocol design and patient finding.

Gain a Truer Picture of Disease Prevalence

Optum Enlighten is a groundbreaking pharma intelligence platform that identifies disease prevalence in populations at a hyper-local level.

Generate Evidence with Real-World Data

Derive evidence from the unmatched depth and scale of our data assets.

Partner with Our Epidemiology Consultants

Advance public health and safety with our trusted experts and data.

Plan with Confidence to Surveil Infectious Diseases

With the Optum® Infectious Disease Platform, you can target the right audience at the right time with the right message using precise data.

Strengthen your value story with HEOR

Tap into our expertise in health economics and outcomes research.

Related healthcare insights

View all

Article

Using epidemiological data build public confidence

See how the FDA and Optum use real-world evidence to monitor the safety and effectiveness of COVID-19 vaccines in our youngest populations.

Guide

Informing FDA best initiative

As a key FDA collaborator, Optum Epidemiology generates reproducible results that inform regulatory decisions for COVID-19 vaccines.

E-book

The 6 trends shaping pharma strategies in 2024

Life sciences market experts from Optum and Advisory Board share perspectives on trends that will influence the future drug value chain.

Article

Monitoring COVID-19 vaccine safety

Discover insights from Dr. John Seeger’s recent participation at the Duke-Margolis Thirteenth Annual Sentinel Initiative Public Workshop.

Find out how we can help you improve health and leverage data in life sciences